Wednesday, December 11, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Nurse’s Death in U.K. Linked to Weight Loss Drug Mounjaro

A 58-year-old nurse’s death has been linked to the popular weight loss drug tirzepatide, sold under the brand name Mounjaro. While her certificate of death lists “multiple organ failure, septic shock, and pancreatitis” as the immediate cause of her passing, “the use of prescribed tirzepatide” is listed as a contributing factor. Susan McGowan had only […]

Pfizer Agrees to Settle Zantac Cancer Lawsuits for $250 Million

Pfizer Agrees to Settle Zantac Cancer Lawsuits for 0 Million

Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines,1 has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States related to cancer risks associated with its over-the-counter heartburn drug Zantac (also known as ranitidine). The acid reflux drug was discontinued in […]

Pfizer Stock Posts Big Drop as Demand for COVID Shots and Paxlovid Dries Up

Pfizer Stock Posts Big Drop as Demand for COVID Shots and Paxlovid Dries Up

The value of shares in Pfizer, Inc. stock has dropped by over eight percent in recent weeks, bringing it to the lowest it has been in more than 10 years. The drop follows a recent announcement by the pharmaceutical company that it will post a decrease in revenue this year that will come in well […]

Blood Pressure Drug Recalled After Oxycodone Found on Production Line

Blood Pressure Drug Recalled After Oxycodone Found on Production Line

Drug manufacturer KVK-Tech, Inc. has issued a voluntary recall of blood pressure drug betaxolol after oxycodone was discovered on the production line. The recall notice, published Sept. 29, 2023 by the U.S. Food and Drug Administration (FDA), says the precautionary measure is being taken following the discovery of a single 5 mg Oxycodone Hydrogen Chloride […]

Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid

Pfizer Will Charge Patients ,390 for COVID Anti-Viral Paxlovid

Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, sold under the brand name Paxlovid. A five-day course of the drug to treat COVID will soon cost patients $1,390.  According to researchers, it costs Pfizer $13 to manufacture the supply of pills […]

Search in Site

To search in site, type your keyword and hit enter

Search